Breaking: Covaxin approved for 2-18 years old

New Delhi, 12/10: In a big development , DCGI approved Bharat Biotech’s COVID-19 vaccine Covaxin for emergency usage on kids aged 2-18.

Bharat Biotech had completed the phase -2 and Phase-3 trial of Covaxin in September on Children below 18 years old.

DCGI said,” After detailed deliberation , the committee recommended for grant of market authorisation to children in age group of 2-18 years old.

Comments are closed.